Personal information

Other IDs

ResearcherID: R-5122-2018

Countries

Spain

Activities

Collapse all

Employment (1)

Institut de Recerca Biomèdica: Barcelona, ES

2018-06 to present | PhD Student
Employment
Source: Self-asserted source
María Caballero de la Torre

Education and qualifications (3)

Universitat Pompeu Fabra: Barcelona, Catalunya, ES

2016 to present | PhD in Biomedicine (Department of Experimental and Health Sciences)
Education
Source: Self-asserted source
María Caballero de la Torre

Universidad de Alcalá de Henares Facultad de Medicina y Ciencias de la Salud: Alcala de Henares, Madrid, ES

2014 to 2015 | Master in Research and Development of Therapeutic Targets in Cell Signaling
Education
Source: Self-asserted source
María Caballero de la Torre

Universidad de Alcalá de Henares: Madrid, Madrid, ES

2010 to 2014 | Bachelor of Biology
Education
Source: Self-asserted source
María Caballero de la Torre

Works (2)

The p38 Pathway: From Biology to Cancer Therapy

International Journal of Molecular Sciences
2020-03-11 | Journal article
DOI: 10.3390/ijms21061913
Contributors: Adrián Martínez-Limón; Manel Joaquin; María Caballero; Francesc Posas; Eulàlia de Nadal
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Somatostatin activates Ras and ERK1/2 via a G protein βγ-subunit-initiated pathway in thyroid cells.

2016-01 | Journal article
DOI: 10.1007/s11010-015-2587-8
PMID: 26472731
Contributors: Rodríguez-Álvarez FJ; Jiménez-Mora E; Caballero M; Gallego B; Chiloeches A; Toro MJ
Source: Self-asserted source
María Caballero de la Torre via Europe PubMed Central
How many people are using ORCID?